BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35156025)

  • 1. Determination of Vitamin D Levels in Patients With Neurofibromatosis Type 1 in the Pediatric Age Group.
    Santos A; Geller M; Mezitis S; Rubenstein AE; Oliveira L; Medeiros Lima DJ; Suchmacher Neto M; Nigri R; Cunha KGS; Takirambudde S; Gonçalves Ribeiro M
    Clin Pathol; 2020; 13():2632010X20928930. PubMed ID: 35156025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
    Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
    Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1.
    Lammert M; Friedman JM; Roth HJ; Friedrich RE; Kluwe L; Atkins D; Schooler T; Mautner VF
    J Med Genet; 2006 Oct; 43(10):810-3. PubMed ID: 16571643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
    Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
    Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor expression and serum 25(OH)D concentration inversely associates with burden of neurofibromas.
    Kluwe L; Hagel C; Friedrich RE; Schnabel C; Schön G; Mautner V
    Eur J Cancer Prev; 2019 May; 28(3):220-224. PubMed ID: 30299316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis without Neurofibromas: Confirmation of a Genotype-Phenotype Correlation and Implications for Genetic Testing.
    Quintáns B; Pardo J; Campos B; Barros F; Volpini V; Carracedo A; Sobrido MJ
    Case Rep Neurol; 2011 Apr; 3(1):86-90. PubMed ID: 21532985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurofibromas in Type I Neurofibromatosis. Description of a clinical case and literature review].
    Del Puerto C; Aspee M; Downey C
    Andes Pediatr; 2022 Oct; 93(5):741-748. PubMed ID: 37906895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences of 25-hydroxyvitamin D3 concentrations in children and adults with neurofibromatosis type 1.
    Schnabel C; Dahm S; Streichert T; Thierfelder W; Kluwe L; Mautner VF
    Clin Biochem; 2014 May; 47(7-8):560-3. PubMed ID: 24613576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1.
    Modica R; Altieri B; D'Aniello F; Benevento E; Cannavale G; Minotta R; Liccardi A; Colao A; Faggiano A
    Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and disease severity in patients with mosaic neurofibromatosis type 1: a single-center study and literature review.
    Ejerskov C; Raundahl M; Gregersen PA; Handrup MM
    Orphanet J Rare Dis; 2021 Apr; 16(1):180. PubMed ID: 33853649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imaging features of neurofibromatosis type 1].
    Jacques C; Dietemann JL
    J Neuroradiol; 2005 Jun; 32(3):180-97. PubMed ID: 16134300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
    Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
    PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
    Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
    J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and follow-up protocol for adult patients with neurofibromatosis type 1 in a Spanish reference unit.
    Solares I; Vinal D; Morales-Conejo M
    Rev Clin Esp (Barc); 2022 Oct; 222(8):486-495. PubMed ID: 35688675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
    Legius E; Brems H
    Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1.
    Trovó-Marqui AB; Goloni-Bertollo EM; Valério NI; Pavarino-Bertelli EC; Muniz MP; Teixeira MF; Antonio JR; Tajara EH
    Braz J Med Biol Res; 2005 Sep; 38(9):1441-7. PubMed ID: 16138229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
    Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.